GO:0030107 HLA-A specific inhibitory MHC class I receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030107 defines a molecular function: combining with an HLA-A MHC class I molecule to mediate signaling that inhibits lymphocyte activation.
• This inhibitory receptor activity is best characterized on natural killer (NK) cells and subsets of T lymphocytes, where it helps distinguish healthy HLA-A-expressing cells from targets [2,4].
• The function is part of the MHC class I-specific receptor system that includes immunoglobulin superfamily inhibitory receptors such as KIR and LILR family members.
• HLA-A allotype diversity and expression levels directly influence the strength of inhibitory signaling and NK cell education [5,8].
• Post-transcriptional regulation of MHC class I, including by RNA-binding proteins such as HNRNPR, can alter the ligand availability for this receptor activity.
• Experimental study of GO:0030107 requires combining receptor-ligand binding assays, lymphocyte functional readouts, and CRISPR-based perturbation of HLA-A or its receptors [2,8].
Description
GO:0030107, HLA-A specific inhibitory MHC class I receptor activity, is a molecular function term describing the binding of a receptor to an HLA-A MHC class I molecule to deliver an inhibitory signal in lymphocytes. This activity is central to how the immune system discriminates between healthy cells, which display HLA-A, and cells that have lost or altered MHC class I expression [2,4]. The term captures a ligand-receptor interaction that suppresses activation rather than promoting it, making it a key node in immune tolerance and surveillance.
HLA-A specific inhibitory MHC class I receptor activity At A Glance
| GO ID | GO:0030107 |
|---|---|
| GO term | HLA-A specific inhibitory MHC class I receptor activity |
| Ontology | molecular_function |
| Synonym | None |
| Major function | Binding to HLA-A MHC class I molecules to mediate inhibitory signaling in lymphocytes |
| Ligand specificity | HLA-A subclass of MHC class I |
| Primary cell types | Natural killer cells and subsets of T lymphocytes [2,4] |
| Signaling outcome | Inhibition of lymphocyte activation |
| Related receptor families | Immunoglobulin superfamily NK cell inhibitory receptors |
What Is GO:0030107?
In practical terms, GO:0030107 describes the function of a receptor when it binds specifically to an HLA-A molecule and, as a result, transmits a signal that reduces or prevents lymphocyte activation. The definition is restricted to the HLA-A subclass of MHC class I, distinguishing it from receptors that recognize other MHC class I allotypes or non-classical MHC molecules [2,4]. This activity is a molecular function, not a process or a cellular component, and it is defined by the combination of ligand specificity (HLA-A) and signaling outcome (inhibition of lymphocyte activation).
Why Is HLA-A specific inhibitory MHC class I receptor activity Important in Cell Biology?
GO:0030107 is important because it represents a fundamental checkpoint in immune recognition: the ability of lymphocytes to read HLA-A as a self-marker and to suppress activation accordingly [2,4]. Disruption of this inhibitory receptor activity can lead to inappropriate lymphocyte activation, while its overactivity may contribute to immune evasion by cells that retain HLA-A expression [2,8]. Understanding this function is therefore relevant to transplantation, viral infection, cancer immunology, and NK cell education [5,8].
• Defines a key inhibitory checkpoint for NK cells and T cell subsets that recognize HLA-A.
• Helps explain how NK cells are educated to tolerate healthy HLA-A-expressing cells.
• Contributes to immune surveillance of cells that lose or alter MHC class I expression [2,4].
• Relevant to viral infections where MHC class I modulation affects lymphocyte responses.
• Relevant to cancer immunology because HLA-A expression levels influence inhibitory signaling.
• Provides a mechanistic basis for allotype-specific differences in NK cell strength.
• Supports research on transplantation compatibility and graft-versus-host responses.
• Guides development of receptor-blocking or ligand-modulating experimental tools.
• Connects to post-transcriptional control of MHC class I availability.
• Offers a defined molecular function for CRISPR-based perturbation studies [2,8].
What Happens During HLA-A specific inhibitory MHC class I receptor activity?
Recognition of HLA-A by the inhibitory receptor
In simple terms: A lymphocyte receptor grabs onto an HLA-A molecule on another cell.
The activity begins when an inhibitory receptor on a lymphocyte binds to an HLA-A MHC class I molecule displayed on a target cell. This interaction is specific for the HLA-A subclass and is part of the broader MHC class I-specific receptor system that includes immunoglobulin superfamily receptors. The binding event itself is the molecular trigger for the inhibitory function defined by GO:0030107.
Transmission of an inhibitory signal
In simple terms: The receptor sends a 'do not attack' signal into the lymphocyte.
Upon HLA-A binding, the receptor mediates signaling that inhibits activation of the lymphocyte. This inhibitory signal counteracts activating pathways and helps maintain tolerance to cells that express normal HLA-A [2,4]. The outcome is a reduced likelihood of lymphocyte activation, which is the defining functional consequence of GO:0030107.
Integration with NK cell education
In simple terms: NK cells learn to respond appropriately based on the inhibitory signals they receive.
In NK cells, HLA-A-specific inhibitory receptor activity contributes to the education process that calibrates responsiveness. The strength of this inhibitory input can vary with HLA-A allotype diversity and expression, influencing genetically determined NK cell strength. This integration ensures that NK cells are more responsive when inhibitory signals are absent or reduced.
Modulation by ligand availability
In simple terms: If HLA-A levels change, the inhibitory signal changes too.
The amount of HLA-A on the cell surface directly affects how much inhibitory signaling can occur. Post-transcriptional regulation of classical and nonclassical MHC class I proteins can alter ligand availability for this receptor activity. Thus, the function of GO:0030107 is not fixed but depends on the cellular context of HLA-A expression.
Key Genes Involved in GO:0030107 HLA-A specific inhibitory MHC class I receptor activity
The genes and proteins most relevant to GO:0030107 include HLA-A itself, the inhibitory receptors that recognize it, and modifiers of MHC class I expression.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HLA-A | Encodes the HLA-A MHC class I ligand recognized by the inhibitory receptor | Central ligand for GO:0030107; target for knockout or point mutation to alter receptor binding |
| KIR3DL1 | Inhibitory receptor that recognizes HLA-A and HLA-B allotypes | Model receptor for studying HLA-A-specific inhibitory signaling |
| KIR3DL2 | Inhibitory receptor with specificity for HLA-A alleles | Used to dissect allotype-specific inhibitory function |
| LILRB1 | Immunoglobulin superfamily inhibitory receptor for MHC class I | Relevant to broader MHC class I inhibitory receptor biology |
| LILRB2 | Immunoglobulin superfamily inhibitory receptor for MHC class I | Provides comparative context for HLA-A-specific inhibition |
| HNRNPR | RNA-binding protein regulating classical and nonclassical MHC class I expression | Modifies HLA-A ligand availability for inhibitory receptor activity |
| B2M | Beta-2-microglobulin, required for MHC class I surface expression | Knockout reduces HLA-A surface display and inhibitory signaling |
| TAP1 | Peptide transporter involved in MHC class I peptide loading | Affects HLA-A peptide repertoire and ligand stability |
| TAP2 | Peptide transporter involved in MHC class I peptide loading | Affects HLA-A peptide repertoire and ligand stability |
| HLA-E | Nonclassical MHC class I molecule recognized by subsets of NK and T cells | Provides contrast to HLA-A-specific inhibitory recognition |
| HLA-B | Classical MHC class I molecule with overlapping receptor specificities | Used to test HLA-A subclass specificity of the receptor activity |
| HLA-C | Classical MHC class I molecule with distinct receptor preferences | Helps define the HLA-A restriction of GO:0030107 |
| CD4 | T cell co-receptor on helper T cells | Relevant to T cell subsets influenced by inhibitory MHC class I signaling |
| CD8A | T cell co-receptor on cytotoxic T cells | Relevant to T cell subsets influenced by inhibitory MHC class I signaling |
| IFNG | Cytokine produced by activated lymphocytes | Readout of lymphocyte activation status in functional assays |
| GZMB | Granzyme B, effector molecule of cytotoxic lymphocytes | Functional readout of lymphocyte activation and cytotoxicity |
| PRF1 | Perforin, effector molecule of cytotoxic lymphocytes | Functional readout of lymphocyte activation and cytotoxicity |
How Is HLA-A specific inhibitory MHC class I receptor activity Regulated?
The activity defined by GO:0030107 is regulated at multiple levels. Ligand availability is controlled by MHC class I expression, which can be influenced post-transcriptionally by RNA-binding proteins such as HNRNPR. Allotype diversity in HLA-A and related MHC class I genes affects the strength of inhibitory signaling and NK cell education. Additionally, the functional responsiveness of NK cells is calibrated by their education state, which determines how they respond to autologous targets.
HLA-A specific inhibitory MHC class I receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HLA-A | Viral infection and immune evasion | HLA-A knockout or point-mutation cell lines to test receptor binding |
| KIR3DL1 | NK cell education and responsiveness | KIR3DL1 knockout NK cell lines for functional assays |
| HNRNPR | Post-transcriptional regulation of MHC class I | HNRNPR knockdown or knockout to measure HLA-A surface levels |
| B2M | MHC class I surface expression | B2M knockout to eliminate HLA-A surface display |
| HLA-E | NK and T cell recognition | HLA-E overexpression to compare nonclassical MHC recognition |
Viral infection and immune evasion
Viruses can modulate MHC class I expression to evade lymphocyte recognition, and the education state of NK cells determines their responsiveness to autologous HIV-infected CD4 T cells. HLA-A-specific inhibitory receptor activity is part of the balance that viruses may perturb to avoid immune clearance.
Cancer immunology
HLA-A expression levels and post-transcriptional regulation of MHC class I proteins can affect inhibitory signaling in the tumor microenvironment. Loss or reduction of HLA-A may reduce inhibitory input and alter lymphocyte activation against tumor cells.
NK cell education and allotype diversity
Adaptive admixture of HLA class I allotypes has enhanced genetically determined strength of natural killer cells in East Asians, illustrating how population-level HLA-A diversity shapes inhibitory receptor function. This has implications for susceptibility to infections and immune-mediated diseases.
From HLA-A specific inhibitory MHC class I receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of HLA-A relieve inhibitory signaling? | HLA-A knockout cell line |
| Does a specific HLA-A point mutation alter receptor binding? | HLA-A point-mutation knock-in |
| Can a tagged HLA-A be used to track surface expression? | Tagged HLA-A knock-in |
| Does overexpression of HLA-A enhance inhibitory signaling? | HLA-A overexpression cell line |
| Does loss of the inhibitory receptor change lymphocyte activation? | KIR3DL1 knockout NK cell line |
| Does modulation of MHC class I regulators affect ligand availability? | HNRNPR knockout or knockdown |
How to Study the HLA-A specific inhibitory MHC class I receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | HLA-A surface protein levels | Confirm knockout or overexpression of HLA-A |
| Cytotoxicity assay | Lymphocyte killing activity | Assess inhibitory signaling effects on NK cells |
| Cytokine ELISA | IFNG production by lymphocytes | Measure activation status after receptor engagement |
| Binding assay | Receptor-HLA-A interaction | Test specificity of inhibitory receptor binding |
| RNA-seq | MHC class I gene expression | Identify regulators of HLA-A availability |
| Western blot | Protein levels of MHC class I components | Validate post-transcriptional regulation |
| CRISPR screening | Genes affecting lymphocyte activation | Discover modifiers of HLA-A-specific inhibition |
Flow cytometry for HLA-A surface expression
Flow cytometry with HLA-A-specific antibodies can quantify surface HLA-A levels, which determine ligand availability for the inhibitory receptor activity. This method is used to confirm knockout or overexpression of HLA-A in model systems.
Lymphocyte activation assays
Functional assays measuring cytokine production or cytotoxicity can assess whether HLA-A-specific inhibitory receptor activity suppresses lymphocyte activation. Readouts such as IFNG, GZMB, and PRF1 are commonly used.
Receptor-ligand binding assays
Binding assays using recombinant inhibitory receptors and HLA-A molecules can directly test the specificity of the interaction defined by GO:0030107. These assays help distinguish HLA-A-specific binding from binding to other MHC class I subclasses.
Transcriptomic and post-transcriptional analysis
RNA-seq and related methods can measure changes in MHC class I gene expression and identify regulators such as HNRNPR that affect HLA-A availability. Such analyses link post-transcriptional control to inhibitory receptor function.
How CRISPR Can Be Used to Study GO:0030107 HLA-A specific inhibitory MHC class I receptor activity
Knockout
CRISPR knockout of HLA-A can eliminate the ligand for GO:0030107, allowing researchers to test whether inhibitory signaling is lost. Knockout of the inhibitory receptor, such as KIR3DL1, can similarly remove the function and reveal its contribution to lymphocyte activation.
Point Mutation
Point mutations in HLA-A can be introduced to alter specific residues involved in receptor binding, enabling fine mapping of the interaction defined by GO:0030107. Such mutants help distinguish allotype-specific effects from general MHC class I recognition.
Knock-in
Knock-in of tagged or variant HLA-A alleles allows tracking of surface expression and receptor engagement in live cells. This approach can be used to study how allotype diversity affects inhibitory signaling strength.
Overexpression
Overexpression of HLA-A or its inhibitory receptor can amplify the inhibitory signal and make downstream effects easier to measure. This is useful for biochemical and functional assays of GO:0030107.
How EDITGENE Supports HLA-A specific inhibitory MHC class I receptor activity Research
Researchers studying HLA-A specific inhibitory MHC class I receptor activity-related genes often need to determine whether a candidate gene is causally involved in ligand availability, receptor engagement, or downstream inhibitory signaling. EDITGENE provides CRISPR-based cell model services to support such causal studies.
Contact EDITGENE today to design your custom CRISPR model for HLA-A specific inhibitory MHC class I receptor activity research.
Frequently Asked Questions About HLA-A specific inhibitory MHC class I receptor activity
What is GO:0030107?
GO:0030107 is the Gene Ontology molecular function term for HLA-A specific inhibitory MHC class I receptor activity, which combines with an HLA-A MHC class I molecule to mediate signaling that inhibits lymphocyte activation.
What does HLA-A specific inhibitory MHC class I receptor activity do?
It binds HLA-A and delivers an inhibitory signal that suppresses lymphocyte activation, helping lymphocytes tolerate healthy HLA-A-expressing cells [2,4].
What genes are involved in HLA-A specific inhibitory MHC class I receptor activity?
Key genes include HLA-A as the ligand, inhibitory receptors such as KIR3DL1 and KIR3DL2, and modifiers of MHC class I expression such as HNRNPR and B2M [2,6].
Which cells use HLA-A specific inhibitory MHC class I receptor activity?
Natural killer cells and subsets of T lymphocytes use this activity to regulate their activation [2,4].
How is HLA-A specific inhibitory MHC class I receptor activity studied?
It is studied using flow cytometry for HLA-A surface levels, lymphocyte activation assays, receptor-ligand binding assays, and CRISPR-based perturbation [2,6,8].
Why is HLA-A specific inhibitory MHC class I receptor activity important in viral infection?
The education of NK cells determines their responsiveness to autologous HIV-infected CD4 T cells, and HLA-A-specific inhibitory signaling is part of this balance.
How does HLA-A diversity affect inhibitory receptor activity?
Adaptive admixture of HLA class I allotypes has enhanced genetically determined strength of natural killer cells in East Asians, showing that allotype diversity shapes inhibitory signaling.
Can CRISPR be used to study HLA-A specific inhibitory MHC class I receptor activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can be used to perturb HLA-A or its receptors and measure effects on lymphocyte activation [2,6].
What is the difference between HLA-A and HLA-E recognition?
HLA-A is a classical MHC class I molecule recognized by specific inhibitory receptors, while HLA-E is nonclassical and recognized by subsets of NK and T cells.
What readouts are used to measure HLA-A specific inhibitory MHC class I receptor activity?
Common readouts include IFNG, GZMB, and PRF1 expression or secretion, as well as cytotoxicity assays.
Conclusion
GO:0030107 defines a precise molecular function: HLA-A-specific inhibitory signaling in lymphocytes. Its study connects MHC class I ligand biology, inhibitory receptor specificity, and lymphocyte education, with relevance to viral infection, cancer, and immune diversity [5,6,8]. CRISPR-based cell models provide a direct way to test causal roles of HLA-A and its receptors in this inhibitory activity [2,6].
References
- 2. Moretta A et al.. 1997. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes.. Immunol Rev 155:105-17 PMID: 9059886
- 3. Pietra G et al.. 2009. HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.. Curr Pharm Des 15(28):3336-44 PMID: 19860683
- 4. Colonna M. 1997. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors.. Immunol Rev 155:127-33 PMID: 9059888
- 5. Deng Z et al.. 2021. Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians.. Mol Biol Evol 38(6):2582-2596 PMID: 33616658
- 6. Reches A et al.. 2016. HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins.. J Immunol 196(12):4967-76 PMID: 27194785
- 8. Kiani Z et al.. 2019. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.. J Virol 93(23) PMID: 31511383
